Wellington Management Group’s BioNTech BNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12M Buy
135,018
+121,951
+933% +$12.5M ﹤0.01% 1198
2025
Q4
$1.24M Buy
+13,067
New +$1.32M ﹤0.01% 1680
2022
Q2
Sell
-176,515
Closed -$30.1M 2082
2022
Q1
$30.1M Sell
176,515
-31
-0% -$5.21K 0.01% 910
2021
Q4
$45.5M Buy
+176,546
New +$48.4M 0.01% 859
2021
Q2
Sell
-366,030
Closed -$40M 2139
2021
Q1
$40M Sell
366,030
-33,362
-8% -$3.54M 0.01% 871
2020
Q4
$32.6M Sell
399,392
-174,912
-30% -$17.2M 0.01% 908
2020
Q3
$39.8M Sell
574,304
-22,908
-4% -$1.64M 0.01% 759
2020
Q2
$39.9M Buy
+597,212
New +$29.8M 0.01% 753

Other funds holding BNTX

Wellington Management Group's BNTX Position: Q1 2026 in Review

Wellington Management Group increased its BioNTech (BNTX) stake by 933% in Q1 2026, buying an estimated $12.5M and bringing the position to 135,018 shares worth $12M. The position accounts for ﹤0.01% of the portfolio, ranked #1198.

Wellington Management Group first reported a position in BNTX in Q2 2020 and has held it in 8 quarters since. The position peaked at $45.5M in Q4 2021. 272 funds tracked by Wall St. Rank hold BNTX as of Q1 2026.

  • Wellington Management Group held 135,018 shares of BioNTech worth $12M as of Q1 2026.
  • Wellington Management Group bought 121,951 BioNTech shares in Q1 2026, an estimated $12.5M.
  • BioNTech made up ﹤0.01% of Wellington Management Group's portfolio in Q1 2026, its #1198 holding.
  • Wellington Management Group first reported a position in BioNTech in Q2 2020 and has held it in 8 quarters since.
  • Wellington Management Group's BioNTech position peaked at $45.5M in Q4 2021.
  • 272 funds tracked by Wall St. Rank held BioNTech as of Q1 2026.

Based on Wellington Management Group's 13F filing for Q1 2026, filed 15 May 2026.